Area of research
Molecular Biology · Hematology
Research interest
Research interests include Nuclear Structure and Function, Multiple Myeloma Research and Treatments, PI3K/AKT/mTOR signaling in cancer, and Retinoids in leukemia and cellular processes.
Abstract PR008: MYTHIC: First-in-human (FIH) biomarker-driven phase I trial of PKMYT1 inhibitor lunresertib (lunre) alone and with ATR inhibitor camonsertib (cam) in solid tumors with <i>CCNE1</i> amplification or deleterious alterations in <i>FBXW7</i> or <i>PPP2R1A</i>
A 2:1 randomized, open-label, phase II study of selinexor vs. physician’s choice in older patients with relapsed or refractory acute myeloid leukemia
Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials
Clinical Implications of Targeting XPO1-mediated Nuclear Export in Multiple Myeloma
Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia
First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors